Form D — Triton Therapeutics, Inc.

0002088152-25-000001 · filed Oct 23, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $36,355,769
Reported amount sold: $36,355,769
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Triton Therapeutics, Inc.
CIK: 2088152
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2025
Address: 700 FAIRFIELD AVENUE, SUITE 1
STAMFORD, CT 06902
Phone: 203-482-3123

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Paul Fonteyne · Executive Officer

Stamford, CT Find on LinkedIn ↗
Annie Mitsak · Director

Boston, MA Find on LinkedIn ↗
Timothy Shannon · Director

Stamford, CT Find on LinkedIn ↗
Elena Grigoryeva · Director

Princeton, NJ Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗